Interactive
Pneumococcal Dashboard
Watch this 2-minute video with Pharmacist and Vaccine Expert Ajit Johal explaining why an interactive dashboard tool addresses an unmet need for immunizing healthcare professionals
Why the Need for a Dashboard?
Your up-to-date, data-driven, and one-stop-shop for pneumococcal vaccine recommendations! Use this as your “North Star” in protecting your older adult and pediatric patients against pneumococcal disease across the lifespan.
Why the Need for a Dashboard?
Your up-to-date, data-driven, and one-stop-shop for pneumococcal vaccine recommendations! Use this as your “North Star” in protecting your older adult and pediatric patients against pneumococcal disease across the lifespan.
Meet Arnold our AI pharmacist and his Digital Assistant Vaccine Expert – AKA D.A.V.E.
Introducing the Dashboard
Data populating this dashboard is updated regularly and references the most up-to-date epidemiology reported by Canada’s National Microbiology Laboratory (NML). Patient-specific vaccination guidelines reference the latest statement on Pneumococcal Disease from the National Advisory Committee on Immunization (NACI). Programmatic coverage reflects the provincial and territorial decisions to fund pneumococcal vaccination for pediatric and adult populations. Finally, the coadministration of available pneumococcal vaccinations and other recommended vaccinations is acceptable as per the Canadian Immunization guide, and is both convenient for at-risk patients, and protects them against disease sooner!
Last updated: July 2026
Recommended Vaccine: No further vaccination needed at this time
Reference: NACI 2024
Recommended Vaccine: PCV 20 or PCV 21
Timing: When the patient recovers and feels well enough to come to the clinic/pharmacy for vaccination
Reference: How long does a pneumonia shot last? , NACI 2024
Recommended Vaccine: PCV 20 + PCV 21
Timing: 1 year (order does not matter) *After consultation with the transplant specialist*
Reference: NACI 2024
| Province | Pediatrics | Adults | |
|---|---|---|---|
| British Columbia | PCV20 | PCV20 | |
| Alberta | PCV 15 (Routine), PCV 20 (High Risk) | PCV 20 (18+ High Risk and 65+) | |
| Saskatchewan | PCV 15 (Routine), PCV 20 (High Risk) | PCV 20 (Risk Factor Eligibility), PCV 21 (65+) | |
| Manitoba | PCV 15 (Routine), PCV 20 (High Risk) | PCV 20 (18+ High Risk and 65+) | |
| Ontario | PCV 15 (Routine), PCV 20 (High Risk) | PCV 20 (18+ High Risk and 65+) | |
| Quebec | PCV 20 (Routine) | PCV21 (65+, 50-64 High Risk), and PCV20 + PCV21 (For Very High Risk) | |
| New Brunswick | PCV 15 | PCV 20 | |
| Nova Scotia | PCV 15 (Routine), PCV 20 (High Risk) | PCV 20 | |
| Newfoundland | PCV 15 (Routine), PCV 20 (High Risk) | PCV 20 (18+ High Risk and 65+) | |
| Prince Edward Island | PCV 13 | PCV 20 (18+ High Risk and 65+) |
Last updated: Feb 2026
The following table has been consolidated from the most recent public health updates in each respective provincial and territorial jurisdiction. Click link on each province for more detailed updates in your region.
Presentation Slides
Click on the image to view the full presentation (pdf).

March Immunization and Antiviral presentation
Date: March 30, 2022
Presenter: Ajit Johal BSP RPh BCPP CTH

BC Expanded Scope Pneumoccocal Presentation
Date: Nov 22, 2022
Presenter: Ajit Johal BSP RPh BCPP CTH